Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.16 USD | -0.96% | -0.95% | +23.96% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
Chart calendar Wave Life Sciences Ltd.
Upcoming events on Wave Life Sciences Ltd.
Past events on Wave Life Sciences Ltd.
2024-05-15 02:30 pm | TIDES USA Congress - Pachamuthu Kandasamy, PhD |
2024-05-15 02:30 pm | TIDES USA Congress - Jack Godfrey, PhD |
2024-05-14 08:30 am | RBC Capital Markets Global Healthcare Conference |
2024-05-10 04:30 pm | American Society of Gene & Cell Therapy Meeting |
2024-05-09 12:00 pm | American Society of Gene & Cell Therapy Meeting |
2024-05-09 08:30 am | Q1 2024 Earnings Call |
2024-05-09 07:30 am | Q1 2024 Earnings Release |
2024-04-11 08:45 am | Needham Healthcare Conference |
2024-04-03 03:10 pm | Cantor Fitzgerald Muscular Dystrophy Symposium |
2024-03-06 08:30 am | Q4 2023 Earnings Call |
2024-03-06 07:30 am | Q4 2023 Earnings Release |
2024-03-04 06:00 pm | Muscular Dystrophy Association Clinical & Scientific Conference - Poster #M168 |
2024-03-03 06:00 pm | Muscular Dystrophy Association Clinical & Scientific Conference - Poster #S10 |
2024-03-03 06:00 pm | Muscular Dystrophy Association Clinical & Scientific Conference - Poster #S14 |
2024-01-10 06:00 pm | JPMorgan Healthcare Conference |
2023-11-29 03:50 pm | Evercore ISI HealthCONx Conference |
2023-11-09 08:30 am | Q3 2023 Earnings Call |
2023-11-09 07:30 am | Q3 2023 Earnings Release |
2023-10-02 10:30 am | Chardan Genetic Medicines Conference |
2023-09-28 10:00 am | R&D Day |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 16,0 18,9 -15.62% | 20,1 20,5 -1.98% | 41,0 52,7 -22.27% | 3,65 4,80 -24.03% | 113 104 8.9% | 67,8 |
EBITDA Million USD | Released Forecast Spread | -199 -196 -1.61% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -208 -201 -3.68% | -153 -150 -2.26% | -127 -121 -5.11% | -163 -157 -3.4% | -68,0 -79,7 14.72% | -139 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -194 -188 -3.14% | -151 -148 -2.15% | -122 -117 -5.03% | -161 -156 -3.62% | -58,2 -70,9 17.97% | -130 |
Net income Million USD | Released Forecast Spread | -194 -188 -3.14% | -150 -148 -1.58% | -122 -115 -6.02% | -162 -156 -3.58% | -57,5 -65,3 11.91% | -119 |
EPS USD | Released Forecast Spread | -5,72 -5,53 -3.36% | -3,82 -3,84 0.62% | -2,36 -2,22 -6.17% | -2,05 -2,01 -1.91% | -0,54 -0,62 12.67% | -0,88 |
Announcement Date | 02/03/20 | 04/03/21 | 03/03/22 | 22/03/23 | 06/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 1,75 3,86 -54.63% | 0,38 3,00 -87.5% | 0,29 5,40 -94.72% | 1,24 2,40 -48.34% | 12,9 38,6 -66.51% | 22,1 7,94 178.5% | 49,2 23,4 110.03% | 29,1 19,8 46.56% | 12,5 25,0 -49.85% | 2,00 | 2,00 | 33,0 | 10,0 | 14,2 |
EBIT Million USD | Released Forecast Spread | -38,1 -35,4 -7.68% | -42,2 -35,2 -19.62% | -38,9 -40,2 3.15% | -43,6 -38,2 -13.93% | -30,3 -1,35 -2147.08% | -23,5 -37,3 37.01% | 4,44 -24,9 117.83% | -18,7 -30,5 38.71% | -34,5 | -47,0 | -46,0 | -18,0 | -40,3 | -36,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -37,8 -34,4 -9.78% | -41,3 -34,5 -19.8% | -39,0 -39,4 0.92% | -43,0 -37,4 -14.97% | -27,4 -0,61 -4390.78% | -21,1 -36,0 41.45% | 6,58 -23,3 128.17% | -16,3 -29,0 43.93% | -31,6 | -46,0 | -45,0 | -18,0 | -38,4 | -35,0 |
Net income Million USD | Released Forecast Spread | -37,8 -33,4 -13.2% | -41,3 -33,8 -22.08% | -39,0 -39,2 0.43% | -43,7 -38,1 -14.61% | -27,4 -6,07 -351.62% | -21,1 -34,9 39.5% | 7,00 -18,9 137.11% | -16,3 -23,9 31.96% | -31,6 | -24,1 | -31,3 | -32,3 | -38,4 | -35,0 |
EPS USD | Released Forecast Spread | -0,62 -0,56 -11.71% | -0,62 -0,54 -15.17% | -0,42 -0,50 15.44% | -0,45 -0,41 -9.76% | -0,27 -0,04 -575% | -0,20 -0,33 39.66% | 0,07 -0,18 139.25% | -0,15 -0,23 33.82% | -0,24 | -0,18 | -0,23 | -0,23 | -0,27 | -0,22 |
Announcement Date | 12/05/22 | 11/08/22 | 10/11/22 | 22/03/23 | 03/05/23 | 03/08/23 | 09/11/23 | 06/03/24 | 10/05/24 | - | - | - | - | - |
Past sector events for Wave Life Sciences Ltd.
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- WVE Stock
- Calendar Wave Life Sciences Ltd.